enzalutamide
Astellas,Pfizer
['ovarian']
#asco2022 #specialcollection phase ii study of #enzalutamide in #androgen #receptor #positive recurrent, high- and low-grade #serous #ovariancancer 
Gynecologic Oncology & Gynecologic Oncology Reports Official Jnls @SGO_org Editors-in-Chief @David_Cohn_MD @SusanModesitt #SocialMediaEditor @GreggNelsonERAS